GDOCvsIHEETF Comparison
VS
Goldman Sachs Future Health Care Equity ETF (GDOC) belongs to the Healthcare Technology segment. iShares U.S. Pharmaceuticals ETF (IHE) is part of the US Health Care segment. GDOC's top 1 sector exposures are Healthcare. In contrast, IHE's top sector exposures are Healthcare and Non-Corporate. GDOC is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.37% for IHE. GDOC is up 4.02% year-to-date (YTD) with -$2M in YTD flows. IHE performs better with 20.93% YTD performance, and +$635M in YTD flows. Run a side-by-side ETF comparison of GDOC and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
GDOC vs IHE performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/18/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GDOC IHE | -1.38%-3.19% | +11.53%+10.77% | +4.02%+20.93% | +13.97%+45.92% | +19.50%+72.78% | n/a+80.08% |
| Flows | GDOC IHE | -+$42M | -$3M+$604M | -$2M+$635M | -$3M+$792M | -$86M+$883M | -+$889M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GDOC IHE | +15.50%+19.68% | +15.27%+18.25% | +14.97%+17.00% | n/a+16.58% |
| Max drawdown | GDOC IHE | -6.08%-6.47% | -15.39%-8.48% | -22.18%-16.04% | n/a-16.12% |
| Max drawdown duration | GDOC IHE | 30d30d | 221d81d | 449d210d | n/a669d |
Trading data
GDOC | IHE | |
Last sale 9/18/2026 at 1:30 PM | $37.02 | $101.53 |
| Previous close 09/17/2026 | $37.25 | $102.27 |
| Consolidated volume 09/17/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GDOC
is actively managed and doesn’t replicate an indexGDOC | IHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/18/2026 at 1:30 PM
Live
Closed
GDOC | IHE | |
|---|---|---|
| Last price | $37.02 | $101.53 |
| 1D performance | -0.62% | -0.72% |
| AuM | $19.46 M | $1.66 B |
| E/R | 0.75% | 0.37% |
Characteristics
GDOC | IHE | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Goldman Sachs | iShares |
| Benchmark | - | Dow Jones U.S. Select Pharmaceuticals Index |
| N° of holdings | 38 | 57 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 11, 2021 | May 1, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
GDOC
USA
79.52%
Other
20.48%
IHE
USA
95.81%
Other
4.19%
Sectors
GDOC
Healthcare
97.92%
Other
2.08%
IHE
Healthcare
99.62%
Other
0.38%
Advertisement
Diversification
GDOC
Total weight of top 15 holdings out of 15
71.18%
IHE
Total weight of top 15 holdings out of 15
84.32%
Top 15 holdings
Data as of July 31, 2026
GDOC
Eli Lilly & Co.
13.11%
Johnson & Johnson
8.63%
Merck & Co., Inc.
6.83%
UnitedHealth Group, Inc.
6.44%
Guardant Health, Inc.
4.41%
argenx SE
3.71%
AstraZeneca PLC
3.59%
Edwards Lifesciences Corp.
3.30%
Thermo Fisher Scientific, Inc.
3.30%
Agilent Technologies, Inc.
3.28%
DexCom, Inc.
3.23%
Apogee Therapeutics, Inc.
3.00%
Intuitive Surgical, Inc.
2.88%
Lonza Group AG
2.79%
Cencora, Inc.
2.67%
IHE
Johnson & Johnson
21.85%
Eli Lilly & Co.
20.71%
Bristol Myers Squibb Co.
4.75%
Viatris, Inc.
4.56%
Merck & Co., Inc.
4.44%
Royalty Pharma Plc
4.41%
Pfizer Inc.
3.96%
Zoetis, Inc.
3.81%
Jazz Pharmaceuticals Plc
3.58%
Elanco Animal Health, Inc.
2.92%
Corcept Therapeutics, Inc.
2.49%
Axsome Therapeutics, Inc.
2.24%
Crinetics Pharmaceuticals, Inc.
1.95%
Liquidia Corp.
1.35%
Ligand Pharmaceuticals, Inc.
1.31%
Frequently asked questions about GDOC and IHE
How have the GDOC and IHE ETFs performed in 2026?
As of September 18, 2026, GDOC is up 4.02% year-to-date (YTD), while IHE has returned 20.93%. That puts IHE better performer ahead so far this year.
Which ETF is attracting more investor money: GDOC or IHE?
Year-to-date, the GDOC ETF saw -$2M in flows, compared to +$635M for IHE.
Which ETF is more volatile: GDOC or IHE?
Over the past year, GDOC had a volatility of 15.27%, while IHE experienced 18.25%.
Which ETF is bigger: GDOC or IHE?
As of September 18, 2026, GDOC holds $19.46 M in assets under management (AUM), while IHE manages $1.66 B.
What sectors do the GDOC and IHE ETFs invest in?
GDOC leans toward sectors like Healthcare. Meanwhile, IHE focuses on Healthcare.
What are the top holdings of the GDOC ETF and IHE ETF?
GDOC top holdings include Eli Lilly & Co., Johnson & Johnson and Merck & Co., Inc.. IHE holds in its top three: Johnson & Johnson, Eli Lilly & Co. and Bristol Myers Squibb Co..
Which ETF is more diversified: GDOC or IHE?
GDOC holds 38 securities with 71.18% of its assets in the top 15. IHE has 57 securities and a top 15 weight of 84.32%.
Advertisement
Latest news about GDOC & IHE
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
November 20, 2023
IHE
Healthcare Stocks Rebound
August 14, 2023
IHE
Health is Wealth: A look at the Healthcare Sector
January 24, 2023
IHE
Advertisement
Advertisement
